|
|
Expert Physicians Discuss Guideline Focused Care in Hereditary Angioedema
Target Audience
This activity is designed to meet the educational needs of clinicians involved in the diagnosis and management of patients with hereditary angioedema (HAE).
Program Overview:
This activity will provide learners with an opportunity to hear expert physicians discuss recently updated guidelines for HAE. The experts will cover important considerations in prophylactic treatment for HAE-C1INH, diagnosis and treatment for HAE-normal-C1INH, and how to create individualized HAE pati... |
|
|
Respiratory Syncytial Virus: Protecting Older Adults at Risk for Serious Complications
Target Audience
This activity was developed for family practice physicians, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for older adults.
Program Overview
Each year, respiratory syncytial virus (RSV) infects up to 10% of older adults who live in congregate settings and predisposes to an increased risk for hospitalization and death, particularly in those with comorbid cardiopulmonary disease. Stefan Gravenstein, MD, MPH, compares the... |
|
|
CSU: An Older African American Adult Male With Widespread, Persistent Pruritus
Target Audience
The target audience will be comprised of allergists, dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care/pharmacy directors.
Program Overview
Chronic spontaneous urticaria (CSU) is a chronic immune-mediated condition characterized by sudden development of wheals and/or angioedema, as well as presenting with significant debilitation and considerable burden on patients’ quality of life. The diagnosis and management of CSU is comp... |
|
|
Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis
Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C
|
|
|
Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis
Target Audience
This educational activity is designed for advanced practice nurses (APRN) including nurses and nurse practitioners (NP), physicians, and other clinicians in a hematology setting treating patients with hemophilia A
Program Overview
Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary, expert... |
|
|
Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent
Target Audience
This online educational activity is directed toward hematologists, primary care clinicians, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the management of hemophilia.
Activity Overview
Over the past 20 years, substantial advances in the treatment of hemophilia A have allowed patients to take greater control of their disease. The primary goals of hemophilia A treatment are to prevent bleeding episodes, reduce lon... |
|
|
Evaluating Emerging Gene Therapies to Further Treatment for Patients with Hemophilia A
Target Audience
This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A.
Program Overview
Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the... |
|
|
Clinical Complications, Challenges, and Comorbidities Assoicated with Hemophilia A and its Treatment
Target Audience
This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A.
Program Overview
Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the... |
|
|
Selecting and Dosing Clotting Factors to Individualize Treatment for Patients with Hemophilia A
Target Audience
This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A.
Program Overview
Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the... |
|
|
Expanding Patient Engagement to Advance Hemophilia A Treatment Adherence and Outcomes
Target Audience
This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A.
Program Overview
Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the... |
|
|
Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care
Target Audience
The target audience for this activity is internists and internal medicine subspecialists. Other primary care providers, nurse practitioners, physician assistants, nurses, and other health care professionals involved in VTE management are invited to participate as well.
Program Overview
Venous thromboembolism (VTE) is a serious and underdiagnosed medical condition that manifests as deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and can cause serious illness, ... |
|
|
BURST Expert Illustrations & Commentaries™: Personalizing Treatment Regimens for Patients with Hemophilia
Target Audience
This educational activity is directed toward hematologists and other health care providers involved in the management of patients with hemophilia A and B.
Program Overview
The mainstay of therapy in hemophilia is supplementation of the missing factor VIII or factor IX proteins. The relatively short plasma half-life of these agents results in the need for frequent intravenous (IV) injections. Attempts have been made to engineer these factors to remain in the circulation... |
|
|
Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy
CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.
1.0 NCPD | ILNA
STATEMENT OF NEED
Chemotherapy-induced peripheral neuropathy (CIPN) is a complication of cancer treatment that may impair quality of life and lead to treatment dose reductions or discontinuation in severe cases. In one study of 123 patients receiving taxane therapy for bre... |
|
|
APhA Pharmacists Association's Pharmacy-Based Travel Health Services
APhA’s Pharmacy-Based Travel Health Services (2nd Edition) is an innovative and interactive advanced competency training (ACT) program that explores the pharmacist’s role in providing travel health services to patients. This application-based activity is the first step for pharmacists interested in learning the essential skills necessary to successfully provide travel health services.
Program pre-requisite: Pharmacists who have completed the APhA Pharmacy-Based Immunization Delivery certi... |
|